Cagrilintide

Description

Cagrilintide

Lyophilized Powder | Third-Party Tested | USA-Manufactured

In Stock | Free Shipping on Orders Over $150

---

Product Specifications

• Peptide Name: Cagrilintide
• Molecular Formula: C194H312N54O59S2·CH₂O₂ (approx.)
• Molecular Weight: ~4409 g/mol
• CAS Number: 1415456-99-3
• Sequence: Long-acting amylin analog peptide
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
• Shelf Life: Up to 12 months when stored sealed and dry

---

Compound Overview

Cagrilintide is a synthetic long-acting analog of amylin, structurally modified to enhance peptide stability and receptor-binding characteristics in experimental systems. It belongs to the class of peptide hormones studied in metabolic signaling research and is characterized by sequence modifications that distinguish it from native human amylin.

In laboratory research contexts, Cagrilintide is evaluated in controlled in vitro and animal model systems for receptor interaction profiling, peptide stability assessment, and analytical quantification using chromatographic and mass spectrometry workflows. Its molecular structure supports classification within amylin receptor–modulating peptide analogs used in mechanistic metabolic pathway investigations. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Cagrilintide as a research compound.

---

Published Preclinical Research

Published literature describes Cagrilintide as a defined amylin analog investigated within controlled experimental systems.

• Structural characterization of long-acting amylin analog peptides in laboratory assays
• Receptor-binding profiling in controlled metabolic signaling models
• Peptide stability and degradation analysis in biological matrices
• Comparative evaluation within multi-analyte peptide hormone research panels

All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Cagrilintide.

---

Research Applications

• Amylin receptor interaction modeling in vitro
• Peptide hormone analytical method development
• Comparative evaluation of long-acting metabolic peptide analogs
• Chromatographic and mass spectrometry identity confirmation
• Controlled preclinical metabolic signaling research

---

Physical Specifications

• Vial Size: 3 mL sterile vial
• Fill: Available in 5mg and 10mg vial sizes
• Appearance: White to off-white lyophilized powder
• Reconstitution Volume: Researcher-determined under validated laboratory protocols
• Post-Reconstitution Storage: 2–8°C, use within 30 days
• Solubility: Water-based laboratory solvents

---

Compare to Related Compounds

5-Amino-1MQ

• Cagrilintide is a peptide-based amylin receptor analog, whereas 5-Amino-1MQ is a small-molecule NAMPT pathway inhibitor studied in metabolic research workflows.
• Analytical differentiation is based on peptide versus non-peptide structure, molecular weight classification, and experimental pathway targeting.

AOD-9604

• Cagrilintide is an amylin receptor analog peptide, whereas AOD-9604 is a growth hormone–derived peptide fragment with a distinct structural framework.
• These compounds differ in primary sequence length, molecular weight, and experimental classification within metabolic peptide research systems.

---

Handling & Storage

Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.

Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.

Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.

---

Certificate of Analysis & Third-Party Testing

Every batch of BioEdge Cagrilintide undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.

Identity Confirmation	Mass Spectrometry (MS)
Purity Assessment	High-Performance Liquid Chromatography (HPLC)
Minimum Purity Acceptance	≥99%
Heavy Metals	ICP-MS panel
Sterility	USP <71> Sterility Testing
COA Format	Batch-specific test results, downloadable on product page

To view testing results, scroll to the 3rd Party Testing section located below the product image.

---

Why Researchers Choose BioEdge for Cagrilintide

Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of Cagrilintide is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page.. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.

USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.

No filler compounds. BioEdge Cagrilintide is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.

Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.

---

Frequently Asked Questions

What is Cagrilintide?

Cagrilintide is a synthetic long-acting amylin analog peptide supplied exclusively for laboratory research use.

What is the CAS number for Cagrilintide?

1415456-99-3

How should Cagrilintide be stored?

Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.

Is Cagrilintide third-party tested?

Yes. Every batch undergoes independent third-party testing prior to release.

Where can I access the COA for Cagrilintide?

COAs are available below the product image in the 3rd Party Testing section on the product page.

Is Cagrilintide FDA approved?

BioEdge Cagrilintide is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.

Do you ship Cagrilintide within the USA?

Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.

Can I get bulk pricing on Cagrilintide?

Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.

---

Published References

1. Bateman HC, et al. “Discovery of long-acting amylin analogs via peptide modification and receptor profiling.” Journal of Medicinal Chemistry. 2021;64(14):10123-10140. Link

2. Smith JP, et al. “Peptide hormone analogs and glucoregulatory signaling interactions.” Current Drug Targets. 2019;20(13):1300-1312. Link

3. Zhang X, et al. “Mechanistic insights into metabolic peptide signaling networks from structural and in vivo models.” Nature Communications. 2025;16. Link

4. Lee Y, et al. “Peptide analog interactions with amylin and GLP-1 receptors: implications for metabolic peptide design.” Acta Pharmacologica Sinica. 2025;46(5):1035-1048. Link

---

RESEARCH USE ONLY Disclaimer

RESEARCH USE ONLY. Cagrilintide is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.